UK markets open in 5 hours

CytomX Therapeutics, Inc. (CTMX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.9200+0.0300 (+1.59%)
At close: 04:00PM EDT
1.8902 -0.03 (-1.55%)
After hours: 07:58PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
119,178
101,214
53,163
37,312
68,427
Operating expenses
Research development
78,557
77,680
111,649
114,194
112,936
Selling general and administrative
29,795
30,018
42,849
39,160
36,031
Total operating expenses
108,352
107,698
154,498
153,354
148,967
Operating income or loss
10,826
-6,484
-101,335
-116,042
-80,540
Total other income/expenses net
-56
-30
340
-83
-27
Income before tax
20,474
3,323
-99,317
-115,870
-78,731
Income tax expense
3,941
3,892
0
0
-13,911
Income from continuing operations
16,533
-569
-99,317
-115,870
-64,820
Net income
16,533
-569
-99,317
-115,870
-64,820
Net income available to common shareholders
16,533
-569
-99,317
-115,870
-64,820
Basic EPS
-0.15
-
-1.51
-1.81
-1.40
Diluted EPS
-0.15
-
-1.51
-1.81
-1.40
Basic average shares
69,945
-
65,740
64,147
46,146
Diluted average shares
69,945
-
65,740
64,147
46,146